Alcohol Use Disorder
Psychiatry·MeSH: Alcoholism
Prevalence
1527.8 / 100K
Incidence
755.8 / 100K/yr
9 drugs in development·7 companies·16 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| AD04 | ADIAL PHARMACEUTICALS, INC. (ADIL) |
Phase 2(3)
Phase 1(2)
Early Phase 1(1)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| cmnd-100 | Clearmind Medicine Inc. (CMND) |
Phase 4(1)
| Drug | Company |
|---|---|
| Tirzepatide | ENANTA PHARMACEUTICALS INC (ENTA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Alcohol Use Disorder?
BioSniper tracks 9 drugs in development for Alcohol Use Disorder across 7 companies.
How many clinical trials target Alcohol Use Disorder?
There are 16 clinical trials targeting Alcohol Use Disorder tracked by BioSniper.
What is the prevalence of Alcohol Use Disorder?
The estimated prevalence of Alcohol Use Disorder is approximately 1527.8 per 100,000 population.
Deep-dive into Alcohol Use Disorder
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis